Sofwave to Participate in Upcoming November Investor Conferences

Core Viewpoint - Sofwave Medical Ltd is actively participating in multiple investor conferences to showcase its innovative aesthetic medical devices and proprietary technology aimed at non-invasive treatments for skin conditions [1][2]. Company Overview - Sofwave Medical Ltd specializes in energy-based non-invasive aesthetic medical devices, focusing on wrinkle reduction, lifting, and cellulite treatment using its proprietary SUPERB™ technology [2]. - The SUPERB™ technology is FDA-cleared for improving facial lines and wrinkles, lifting the eyebrow, and enhancing skin laxity in various areas, including the upper arms and beneath the chin [2]. - The company's Pure Impact™ module utilizes EMS technology for muscle toning and is also FDA-cleared [2]. Upcoming Investor Conferences - Sofwave Medical will present at the following conferences: - Stifel 2025 Healthcare Conference on November 12, 2025, at 10:40 a.m. ET [1]. - Jefferies London Healthcare Conference on November 19, 2025, at 9:30 a.m. GMT [1]. - Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 20, 2025, at 9:30 a.m. ET [2].